NEW YORK, Dec. 9-Affymetrix has partnered with laser capture microdissection company Arcturus, the company said today.
Through the partnership, Arcturus will be able to use Affymetrix' chips and gene expression tools in order to develop new array-based diagnostic products.
Affymetrix invested $3 million in Arcturus as part of a recent round of financing.
Arcturus, based in Mountain View, Calif., develops instruments for "microgenomics"-analyzing nucleic acids and proteins from laser captured cells. The company is also working to develop this technique for new diagnostics.
For more information, see the company website.